ResMed India conducted educational training

S Singh
S Singh
· 4 min read
medical devices

ResMed is a world-leading connected health company which is present in approximately 100 countries with more than 6 million cloud-connected devices for daily remote patient monitoring. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions.

ResMed India is centered around people and technology that are changing the face of healthcare. ResMed Academy is the clinical arm of ResMed in India, conducts educational workshops for medical experts throughout the year in the fields of NIV and Sleep for education and patient benefit.

A one-day workshop on the application of Non- invasive ventilation in hospital and homecare environment – where more than 30 young and aspiring chest Physicians/ pulmonologists attended, this one its kind workshop in New Delhi on January 6, 2019, at Hotel Lalit.

This workshop covered both theoretical and hands-on learning on the application of Non-invasive ventilation across a variety of patients in various types of respiratory failure including Hypoxemic failure, Chronic care, NIV Guidelines etc. Non- invasive ventilation is the airway support system through an interface such as full face mask which gives positive end-expiratory pressure and improves ventilation – and is very effective in managing various forms of respiratory failure, especially COPD.

COPD is a collective term used to describe progressive lung emphysema, chronic bronchitis, refractory asthma and bronchiectasis leading to breathlessness. It is one of the leading causes of deaths in India, especially during winters. A survey claimed 12 lac plus deaths in 2017-18 through both outdoor and indoor pollution. The most common causes and risk factors for COPD are smoking, second-hand smoke, fumes, chemical and dust in construction sites.

Patients benefit from NIV as it provides pressure support and which assists patient’s breathing to enable more volume to enter into their lungs in a shorter period of time. This decreases their work of breathing (WOB) which lowers their respiratory rate and allows more time to exhale.

The workshop was headed by Dr. Animesh Arya, Senior Pulmonologist & Sleep Specialist, Action Balaji followed by Dr Bharat Gopal, Dr PP Bose and Dr Arunesh Kumar from Maharaj Agrasen, National Heart Institute and Paras Hospital respectively, who are experts in the field of Non- Invasive ventilation. Dr Arya spoke about the indications and Goals of NIV whereas Dr Gopal discussed its role in Hypoxemic respiratory failure. In order to spur this application, for the patient benefit or end users, training was followed by experiential learning on NIV application, monitoring and troubleshooting by Dr. Ashwini Mandanna, Clinical Specialist, ResMed India

The workshop offered all stakeholders in the healthcare system a platform to learn, share and connect. The workshop brings together a multi-disciplinary audience from across the healthcare spectrum to share their experiences, ideas and break the conventional silos that exist in this field.

A non-conventional ventilator which people normally believe can be usually used with the mask, maintaining patient’s awake fullness, ability to communicate and eat and drink. This offers the major advantage, avoiding sedation, and patient comfort, ambulation movement), patient recovery, decreased cost to the patient, early discharge

On the occasion, Dr.  Animesh Arya said, “NIV has become a first standard of care in various patients of chest diseases with respiratory failure and higher levels of carbon dioxide in blood with early recover. The workshop specifically touched the newer concepts in delivery of NIV to wide range of patients”.

“I congratulate, ResMed Academy for conducting such educational workshop that sensitizes and improves the knowledge of upcoming doctors, hence increasing the adoption of NIV.  I look forward to more such initiatives by Resmed”, he added.

Dr Bharat Gopal praised ResMed Academy’s effort and said, “Such workshop is important for early usage of technology after proper intensive training, leading to an excellent outcome to patients suffering from flu/ H1N1, and avoidance of ventilation and associated complications”. He also emphasized, on conducting more of such training programs/ workshops in tier 2 and tier 3 cities to spread the awareness.

As per Dr. P P Bose, skilling the new task force is too important especially when the companies are introducing innovative products every day for patient benefit. Dr Bose, strongly advocates, train the trainee (TTT) model to introduce new technology in patient care.

Dr. Arunesh Kumar said, “such workshops are excellent platforms to share experiences and clinical awareness not only to the Medical fraternity but to the supporting staff such as critical care nurses and respiratory technicians”.

“I am glad ResMed Academy has taken such initiative of giving hands-on learning experience to all levels of medical support staff” he added

Read Next

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk